AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Heidelberg Pharma AG

Declaration of Voting Results & Voting Rights Announcements Mar 4, 2009

201_dva_2009-03-04_6c653245-163c-42aa-a57f-13be7c3be2b7.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 4 March 2009 12:07

WILEX AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

WILEX AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

Release of a Voting Rights announcement, transmitted by DGAP - a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.


WILEX AG: Publication according to Section 26 paragraph 1 of the Securities
Trading Act (Stimmrechtsmitteilung nach § 26 Abs. 1 Wertpapierhandelsgesetz
- WpHG) for Europe-wide distribution:

  1. UCB Pharma S.A., Brussels, Belgium, informed us on 03 March 2009
    according to Section 21 paragraph 1 of the Securities Trading Act
    ('Wertpapierhandelsgesetz', WpHG), that their voting interest in WILEX AG,
    Grillparzerstr. 10, 81675 Munich, Germany (WKN 661472, ISIN DE0006614720
    respectively) has exceeded the thresholds of 3%, 5% and 10% and amounted to
    13.19% (1,818,181 voting rights) on 26 February 2009. All 1,818,181 voting
    rights and the underlying shares are directly held by UCB Pharma S.A.

  2. UCB S.A., Brussels, Belgium, informed us on 03 March 2009 according to
    Section 21 paragraph 1 of the Securities Trading Act
    ('Wertpapierhandelsgesetz', WpHG), that their voting interest in WILEX AG,
    Grillparzerstr. 10, 81675 Munich, Germany (WKN 661472, ISIN DE0006614720
    respectively) has exceeded the thresholds of 3%, 5% and 10% and amounted to
    13.19% (1,818,181 voting rights) on 26 February 2009. All 1,818,181 voting
    rights were attributed to UCB S.A. according to Section 22 paragraph 1
    sentence 1 no. 1 of the Securities Trading Act ('Wertpapierhandels-gesetz',
    WpHG) by UCB Pharma S.A.

  3. Financière de Tubize S.A., Brussels, Belgium, informed us on 03 March
    2009 according to Section 21 paragraph 1 of the Securities Trading Act
    ('Wertpapierhandelsgesetz', WpHG), that their voting interest in WILEX AG,
    Grillparzerstr. 10, 81675 Munich, Germany (WKN 661472, ISIN DE0006614720
    respectively) has exceeded the thresholds of 3%, 5% and 10% and amounted to
    13.19% (1,818,181 voting rights) on 26 February 2009. All 1,818,181 voting
    rights were attributed to Financière de Tubize S.A. according to Section 22
    paragraph 1 sentence 1 no. 1 of the Securities Trading Act
    ('Wertpapierhandelsgesetz', WpHG) by UCB S.A. and UCB Pharma S.A.

Munich, 04 March 2009
WILEX AG
Executive Management Board

04.03.2009 Financial News transmitted by DGAP

Language: English
Issuer: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Internet: www.wilex.com

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.